Skip to main content
PepStack
Blutwerte · Marker

Vitamin K2 (MK-7)

Menaquinone-7 · MK-7 · Vitamin K2

Vitamine & Nährstoffe
Einheit:
ng/mL
Abbreviation
K2 / MK-7

Vitamin K2 (MK-7) measures the concentration of menaquinone-7 in the blood, reflecting its availability for biological processes like protein carboxylation.

Reference Ranges

Reference
0.123.54ng/mL
0.12
3.54
LowNormalHigh
Reference
Unit · ng/mL

Reference range established for healthy women of childbearing age; may vary in other populations.

Overview

Übersicht

Vitamin K2 (MK-7), also known as menaquinone-7, is a fat-soluble vitamin that plays a crucial role in the carboxylation of specific proteins required for blood coagulation and bone health. It is one of the subtypes of Vitamin K2, distinguished by its longer side chain, which affects its bioavailability and half-life in the body. Researchers have observed that MK-7 is integral in activating proteins like osteocalcin and matrix Gla-protein, which are essential for bone mineralization and preventing vascular calcification. Clinically, Vitamin K2 (MK-7) is significant for its role in maintaining cardiovascular and bone health. Deficiency in MK-7 has been linked to increased risks of osteoporosis and arterial calcification, particularly in populations with chronic kidney disease or those undergoing dialysis. In the context of athletic performance and longevity, MK-7 is valued for its potential to enhance bone strength and reduce cardiovascular risks, thereby supporting overall physical resilience and longevity. Biohackers may focus on optimizing MK-7 levels to leverage its benefits on bone density and vascular health. However, researchers found that factors such as chronic kidney disease and certain medications can interfere with MK-7 metabolism and efficacy. Additionally, the time of day and fasting status do not significantly affect MK-7 levels, but lipid levels can influence its absorption. Therefore, consistent dietary intake and consideration of individual health conditions are crucial for accurate assessment and optimization of MK-7 levels.

Klinische Bedeutung

Elevated MK-7 levels generally indicate sufficient vitamin K status, supporting bone and cardiovascular health. Reduced levels may suggest a deficiency, increasing the risk of osteoporosis and vascular calcification, particularly in individuals with chronic kidney disease or on dialysis.

Dynamics

Trend Interpretation

Rising Values

Progressively rising MK-7 levels suggest improved vitamin K status, beneficial for bone and cardiovascular health. Re-test annually to monitor status.

Falling Values

Progressively falling MK-7 levels may indicate worsening vitamin K status, increasing risk for bone and vascular issues.

Re-test Interval

4 weeks if outside optimal range

Etiology

Causes — High & Low

Cause

Elevated Levels

  • High dietary intake of fermented foods
  • Supplementation with MK-7
  • Improved intestinal absorption
  • Reduced metabolic clearance
Cause

Low Levels

  • Chronic kidney disease
  • Poor dietary intake
  • Use of certain medications (e.g., statins)
  • Malabsorption syndromes
Protocol

How to Optimize

Lever

Lifestyle

  • Regular weight-bearing exercise
  • Avoid smoking
  • Manage chronic conditions like CKD
Lever

Nutrition

  • Consume fermented foods like natto
  • Increase intake of leafy greens
  • Incorporate dairy products
Lever

Supplementation

  • MK-7 supplements
  • Vitamin D
  • Calcium

Note:

Consult a healthcare provider before beginning any supplementation, especially if on medication or with chronic health conditions.

Testing Guidelines

Fasting Not Required
Not Time-Sensitive

Vitamin K levels may vary; morning samples recommended for consistency.

Testing Frequency

Annually for general health monitoring, more frequently if managing specific health conditions.

Interfering Factors

  • Lipid levels
  • Certain medications
  • Chronic kidney disease

Open Research Questions

Current research suggests that reference ranges for vitamin K2 (MK-7) in various populations, particularly in childbearing women, are not universally recognized, leading to potential misinterpretation of vitamin K status. Researchers have not yet established optimal targets for MK-7 supplementation in specific patient populations, such as those with chronic kidney disease or diabetes. Additionally, clinical questions remain unanswered regarding the long-term effects of MK-7 on vascular health and its role in mitigating arterial calcification.

16 Research Publications

124

Total Citations

11

Human/RCT

1.7

Avg. Influence

2026

Latest

Sort
Filter
#01

Altered vitamin K biodistribution and metabolism in experimental and human chronic kidney disease.

HumanInfluence2.0
35
Researchers investigated vitamin K metabolism in patients with chronic kidney disease (CKD). They found that CKD patients had reduced uptake of MK-7 into lipoproteins, indicating impaired vitamin K transport and metabolism in this population.
View on PubMed
#02

Vitamin K (phylloquinone and menaquinones) in foods - Optimisation of extraction, clean-up and LC-ESI-MS/MS method for quantification.

In Vitro
20
Researchers optimized a method for quantifying vitamin K in foods, including MK-7. They validated the method across various food matrices, demonstrating its effectiveness for assessing vitamin K content in dietary sources.
View on PubMed
#03

Dramatic Decrease of Vitamin K2 Subtype Menaquinone-7 in COVID-19 Patients.

Human
16
This study analyzed vitamin K levels in COVID-19 patients compared to healthy controls. Researchers observed significantly lower levels of MK-7 in COVID-19 patients, suggesting that the disease may impact vitamin K metabolism.
View on PubMed
#04

Reference Range of Vitamin K Evaluating Indicators in Chinese Childbearing Women.

HumanInfluence2.0
11
Researchers aimed to establish reference ranges for vitamin K indicators in healthy women of childbearing age in China. They found specific reference ranges for serum levels of vitamin K1, MK-4, and MK-7, which can help assess vitamin K nutritional status in this demographic.
View on PubMed
#05

Vitamin K for Vascular Calcification in Kidney Patients: Still Alive and Kicking, but Still a Lot to Learn.

Neofytou Ioannis Eleftherios, et al. · Nutrients · 2024

ReviewInfluence1.0
11
This review discussed the role of vitamin K in vascular calcification among patients with chronic kidney disease. Researchers highlighted the association between vitamin K levels and cardiovascular disease risk, emphasizing the need for more clinical trials on vitamin K supplementation.

Key findings

  1. 01Researchers observed that vascular calcification is a major issue for patients with chronic kidney disease, contributing to cardiovascular problems.
  2. 02They found that vitamin K is important for regulating vascular calcification through specific proteins.
  3. 03Despite promising pre-clinical data, clinical trials on vitamin K supplementation have shown mixed results.
View on PubMed
#06

Adaptive laboratory evolution for improved tolerance of vitamin K in Bacillus subtilis.

In Vitro
9
Researchers developed a method to enhance the production of MK-7 in Bacillus subtilis through adaptive laboratory evolution. They found that the evolved strain produced significantly more MK-7, which could have applications in probiotic formulations.
View on PubMed
#07

Identification of Carotenoids and Isoprenoid Quinones from Asaia lannensis and Asaia bogorensis.

In Vitro
8
Researchers identified carotenoids and isoprenoid quinones produced by strains of acetic acid bacteria. They found that these strains could biosynthesize menaquinone-7 among other compounds. The study provides insights into the metabolic capabilities of these bacteria and their potential applications in food science.
View on PubMed
#08

The effect of six-month oral vitamin K supplementation on calcification propensity time in individuals with type 2 diabetes mellitus: A post hoc analysis of a randomized, double-blind, placebo-controlled trial.

Meer R, et al. · Atherosclerosis · 2024

Human
8
This post-hoc analysis evaluated the impact of vitamin K supplementation on arterial calcification in individuals with type 2 diabetes. Researchers found no significant effect of MK-7 supplementation on calcification propensity time, suggesting further research is needed.

Key findings

  1. 01The study involved 68 participants with an average age of 69 years.
  2. 02Participants were divided into two groups: one received vitamin K and the other a placebo.
  3. 03Researchers observed no effect of vitamin K supplementation on arterial calcification over the six-month period.
View on PubMed
#09

Vitamin K1 and K2 in the Diet of Patients in the Long Term after Kidney Transplantation.

Human
2
Researchers assessed dietary intake of vitamin K in kidney transplant recipients. They found adequate intake of vitamin K1 but insufficient levels of MK-7, indicating a potential risk of vitamin K deficiency in this population.
View on PubMed
#10

No Detectable Coagulation Activation After Vitamin K (MK-7) Supplementation in Patients on Dialysis With Functional Vitamin K Deficiency: A One-Year Randomized, Placebo-Controlled Study.

Bladbjerg Else-Marie, et al. · Journal of renal nutrition : the official journal of the Council on Renal Nutrition of the National Kidney Foundation · 2024

Human
2
This study examined the effects of vitamin K2 (MK-7) supplementation on coagulation biomarkers in patients on dialysis. Researchers found no detectable changes in coagulation activation or adverse events after one year of supplementation, indicating no procoagulant effects from MK-7 in this population.

Key findings

  1. 01Researchers observed no detectable effects on blood clotting markers after one year of vitamin K supplementation.
  2. 02There was a significant decrease in a specific biomarker (PIVKA-II) in the vitamin K group compared to the placebo group.
  3. 03No differences in adverse events or serious complications were noted between the vitamin K and placebo groups.
View on PubMed

Publication Trend

Research publications about Vitamin K2 (MK-7) over time

10total
1
'20
1
'21
2
'22
3
'23
3
'24

Track your bloodwork in PepStack

Log lab results, track trends and optimize your biomarkers over time.

Legal Disclaimer

This page is for informational and research purposes only. All information is based on published scientific literature and does not constitute medical advice, diagnosis, or treatment recommendations. Many substances listed may not be approved for human use and may be subject to drug regulation laws (e.g., AMG in Germany, FDA in the US). PepStack does not encourage the use of any substance on humans. Always consult a qualified healthcare professional before making any health-related decisions. Use of this information is entirely at your own risk. PepStack assumes no liability for the accuracy, completeness, or timeliness of the content provided. Full disclaimer